Thanks for highlighting Elad Sharon — finished my 20 pt clinic & just saw this! Truly an honor to contribute at a high level for #clinicalresearch UTSW Simmons Cancer Center UT Southwestern Medical Center esp w center grant renewal next yr. Grateful to Carlos L. Arteaga, M.D. for the opportunity!

#AUA24 Shilpa Gupta Avel 1L maintenance for aUC: Long-term outcomes from JAVELIN Bladder 100 in subgroups -- 1L chemo regimen and analysis of OS from start of 1L chemo UroToday.com

📍Overall pop: mOS from start 1L chemo - 29.7 mos for Avel + BSC vs 20.5 mos for BSC alone (HR 0.77,…

⏰Don't miss the #KCRS24 abstract submission deadline, folks!
Excellent opportunity to learn latest advancements in #KidneyCancer research, meet the #GUOnc community and build new collaborations.
📅 Mon 5/6
Link 👉tinyurl.com/3xthrwk4
Hope to see you all in Boston!…

Best part of conferences is time w friends who become family. Lovely 36h in San Antonio learning & sharing w Sarah P. Psutka MD MS Xiao Wei, MD Dena Battle Michael Staehler Lauren Meehan Machos, MPH
Not pictured: Petros Grivas Neeraj Agarwal, MD, FASCO #EvanYu KSridhar Brian Shuch, MD Eric A. Singer, MD, MA, MS, FACS, FASCO
Thanks #AUA24 !

New ⁦American Cancer Society⁩ report:
Mortality Trends Among Asian American, Native Hawaiian, and Other Pacific Islander Patients With Preventable Cancers ascopost.com/news/may-2024/…

Congrats ari hakimi !!

Superpower panel of uro-oncology colleagues for the YUO SUO-CTC clinical trials update! Much happening w great growth of YUO over past few years, expanding portfolio of trials. #TogetherWeCan #AUA24
Brian Shuch, MD Viraj Master Sia Daneshmand, M.D. Scott Eggener Gennady Bratslavsky

Thanks for highlighting Anobel Odisho! Greatly appreciate YUO for the opportunity to discuss adjuvant #kidneycancer ! #AUA24

#AUA24 Tian Zhang, MD, MHS delved into risk stratification for adjuvant therapy in high-risk RCC at the SUO meeting at AUA. Key takeaways:

🚩Trial populations differ by risk and exposure to subsequent treatment - impacting outcomes
🚩Balance benefits vs. risks of adjuvant therapy…

Updates on risk stratification for #kidneycancer at #AUA24 Society of Urologic Oncology session by Tian Zhang, MD, MHS
👉Can calculate prognosis with ECOG-ACRIN Cancer Research Group ASSURE nomogram, easy to use: cancernomograms.com/nomograms/492 (@UroCorrea et al) #kcsm #AUA2024

Great session on #kidneycancer continuum and translational work from W. Marston Linehan Ram Srinivasan Mark Ball, MD, FACS #DavidMcdermott Uromigos #AUA24

Kidney Cancer KCCure KidneyCAN KidneyCancerProgram

Amazing cover story about ⁦Karen Knudsen, MBA PhD⁩ of ⁦American Cancer Society⁩ from ⁦The Cancer Letter⁩ today! Great turnaround of a critically important organization! cancerletter.com

🕹️The #uRCADE contest is now on! Stop by SIU booth 1955 at #AUA24 starting today & play the RCC Quest or I-O+ Challenger! Take on the challenge for a chance to win free registration to #SIU2024NewDelhi !

Play online: bit.ly/4d8ftrD
Contest rules:…

Proud to share the work exploring associations between #Resilience , #PsychologicalResources & #HRQOL and #MentalHealth in patients with bladder cancer UW Urology, led my incredible mentee, Erin Petersen MS2 University of Washington. Thank you Bladder Cancer Advocacy Network for supporting this work! #AUA2024

The developmental IO oral session ASCO #ASCO24 will be stacked with good trials! Looking forward to a stellar lineup and working w co-chair Rafeh Naqash, MD.

Welcome Michael Staehler to UT Southwestern Urology UTSW Simmons Cancer Center! Gives a thoughtful discussion on adjuvant risk stratification for #kidneycancer at urology grand rounds.
Kidney Cancer KCCure KidneyCAN

#APCCC24 Advanced Prostate Cancer Consensus Conference 👉 How to monitor and manage toxicities with Lutetium-177 PSMA RLT? #LuisEmmett 👉adaptive dosing based on SPECT scan results may improve toxicity, & rule out disease progression before assuming marrow toxicity👇OncoAlert PCF Science

⁦Advanced Prostate Cancer Consensus Conference⁩ with #lancet commission panelists discussing the challenges managing PC inequities in Africa, Asia, and Latin America. Increasing awareness and screening a key priority.

#APCCC2024 Advanced Prostate Cancer Consensus Conference 👉 Insight talk by #KaimFizazi on Rx of mCRPC #prostatecancer after triplet therapy in mHSPC 👉tumor biology to soon guide treatment & treatment options in the near future👇OncoAlert UroToday.com PCF Science silke gillessen

#APCCC2024 Advanced Prostate Cancer Consensus Conference 👉 Excellent points raised by Ian Davis on sequencing of Rx in metastatic #prostatecancer 👉key principles & his suggestions for sequencing of Rx👇OncoAlert PCF Science silke gillessen